title: [Yiqigushen capsule combined with levofloxacin highly effective for type III A prostatitis].
abstract: OBJECTIVE
  To evaluate the clinical efficacy of the Chinese medicine Yiqigushen Capsule combined with levofloxacin on type III A prostatitis.
  
  
  METHODS
  A total of 180 patients with type III A prostatitis were equally randomized into a treatment group, which received Yiqigushen Capsule combined with levofloxacin, and a control group, which was given Yiqigushen Capsule only, both for 4 weeks. NIH-CPSI scores and leukocyte counts in the expressed prostatic secretions of all the patients were analyzed before and after the treatment.
  
  
  RESULTS
  After the treatment, NIH-CPSI scores and leukocyte counts in the expressed prostatic secretions of both the groups were significantly decreased compared with pre-treatment (P < 0.05 or 0.01), with statistic differences in NIH-CPSI scores but not in leukocyte counts (P < 0.05) between the two groups.
  
  
  CONCLUSIONS
  Yiqigushen Capsule combined with levofloxacin is highly effective for type III A prostatitis.
authors.affiliation: Department of Andrology, Ren'ai Hospital of Guangzhou, Guangzhou, Guangdong 510175, China.
authors.forename: Dong-Fa
authors.initials: DF
authors.lastname: Guo
authors.forename: Hui-Ze
authors.initials: HZ
authors.lastname: Zhang
authors.forename: Huai-Peng
authors.initials: HP
authors.lastname: Wang
mesh_terms: D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002214:Capsules; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use*; D011472:Prostatitis / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000892:Anti-Infective Agents, Urinary; D002214:Capsules; D004365:Drugs, Chinese Herbal; C528832:yiqigushen; D064704:Levofloxacin; D015242:Ofloxacin